Richard Giltner - Nov 5, 2024 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Nov 5, 2024
Transactions value $
-$2,062,722
Form type
4
Date filed
11/6/2024, 04:30 PM
Previous filing
Jul 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $1.75M +10K +57.41% $175.43 27.4K Nov 5, 2024 Direct
transaction UTHR Common Stock Sale -$3.27M -8.57K -31.26% $381.61 18.8K Nov 5, 2024 Direct F1
transaction UTHR Common Stock Sale -$546K -1.43K -7.58% $382.28 17.4K Nov 5, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Stock Options Options Exercise $0 -10K -66.67% $0.00 5K Nov 5, 2024 Common Stock 10K $175.43 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $381.08 to $382.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $382.13 to $382.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.